prof. dr. H.J. (Hidde) Haisma

Professor Therapeutic Gene Modulation

prof. dr. H.J. (Hidde) Haisma
Telephone:
+31 50 36 38174 (Secretariat)
E-mail:
h.j.haisma rug.nl

Research

Postal address:
A Deusinglaan1
Gebouw 3211, ruimte 0306
9713 AV
Groningen
Netherlands
Phone: +31 50 363 6865
  1. 2007
  2. 2006
  3. Mahasreshti, PJ., Kataram, M., Wu, HJ., Yalavarthy, LP., Carey, D., Dent, P., ... Curiel, DT. (2006). Ovarian cancer targeted adenoviral-mediated mda-7/IL-24 gene therapy. Gynecologic Oncology, 100(3), 521-532. https://doi.org/10.1016/j.ygyno.2005.08.042
  4. Haisma, HJ., De Hon, O., Sollie, P., & Vorstenbosch, J. (2006). Genetische doping. Nederlands Tijdschrift voor Klinische Chemie en Laboratoriumgeneeskunde, 31(1), 19.
  5. Haisma, H., Coward, W. A., Visser, G. H., Vonk, R. J., Wells, C. K., Wright, A., & Victora, C. G. (2006). Socio-economic and environmental factors influence energy utilisation in Brazilian breast-fed infants. J. Nutrition, 136, 2945 - 2951.
  6. 2005
  7. Oosterhoff, D., Overmeer, RM., de Graaf, M., van der Meulen, IH., Giaccone, G., van Beusechem, VW., ... Gerritsen, WR. (2005). Adenoviral vector-mediated expression of a gene encoding secreted, EpCAM-targeted carboxylesterase-2 sensitises colon cancer spheroids to CPT-11. British Jounal of Cancer, 92(5), 882-887. https://doi.org/10.1038/sj.bjc.6602362
  8. Lu, B., Makhija, SK., Nettelbeck, DM., Rivera, AA., Komarova, S., Zhou, F., ... Zhu, ZB. (2005). Evaluation of tumor-specific promoter activities in melanoma. Gene Therapy, 12(4), 330-338. https://doi.org/10.1038/sj.gt.3302385
  9. 2004
  10. Kirby, TO., Rivera, A., Rein, D., Ulasov, N. V., Breidenbach, M., Kataram, M., ... Curiel, DT. (2004). A novel ex vivo model system for evaluation of conditionally replicative adenoviruses therapeutic efficacy and toxicity. Clin.Cancer Res., 10(24), 8697 - 8703.
  11. Leath, CA., Kataram, M., Bhagavatula, P., Gopalkrishnan, RV., Dent, P., Fisher, PB., ... Mahasreshti, PJ. (2004). Infectivity enhanced adenoviral-mediated mda-7/IL-24 gene therapy for ovarian carcinoma. Gynecologic Oncology, 94(2), 352 - 362. https://doi.org/10.1016/j.ygyno.2004.04.028
  12. 2003
  13. van Beusechem, V. W., Mastenbroek, D. C., Van den Doel, P. B., Lamfers, M. L., Grill, J., Wurdinger, T., ... Gerritsen, W. R. (2003). Conditionally replicative adenovirus expressing a targeting adapter molecule exhibits enhanced oncolytic potency on CAR-deficient tumors. Gene Therapy, 10(23), 1982-1991. https://doi.org/10.1038/sj.gt.3302103
  14. Bruell, D., Stocker, M., Huhn, M., Redding, N., Kupper, M., Schumacher, P., ... Barth, S. (2003). The recombinant anti-EGF receptor immunotoxin 425(scFv)-ETA' suppresses growth of a highly metastatic pancreatic carcinoma cell line. Int.J.Oncol., 23(4), 1179-1186.
  15. Mahasreshti, P. J., Kataram, M., Wang, M. H., Stockard, C. R., Grizzle, W. E., Carey, D., ... Curiel, D. T. (2003). Intravenous delivery of adenovirus-mediated soluble FLT-1 results in liver toxicity. Clin.Cancer Res., 9(7), 2701 - 2710.
  16. 2002
  17. de Gruijl, TD., Luykx-de Bakker, SA., Tillman, BW., van den Eertwegh, AJM., Buter, J., Lougheed, SM., ... Gerritsen, WR. (2002). Prolonged maturation and enhanced transduction of dendritic cells migrated from human skin explants after in situ delivery of CD40-targeted adenoviral vectors. Journal of Immunology, 169(9), 5322-5331.
  18. Oosterhoff, D., Pinedo, HM., van der Meulen, IH., Sone, T., Kruyt, FA., van Beusechem, VW., ... Gerritsen, WR. (2002). Secreted and tumour targeted human carboxylesterase for activation of irinotecan. British Jounal of Cancer, 87(6), 659-664. https://doi.org/10.1038/sj.bjc.6600519
  19. Dirven, CMF., Grill, J., Lamfers, MLM., Van der Valk, P., Leonhart, AM., Van Beusechem, VW., ... Gerritsen, WR. (2002). Gene therapy for meningioma: improved gene delivery with targeted adenoviruses. Journal of Neurosurgery, 97(2), 441-449.
  20. van der Poel, HG., Molenaar, B., van Beusechem, VW., Haisma, HJ., Rodriguez, R., Curiel, DT., & Gerritsen, WR. (2002). Epidermal growth factor receptor targeting of replication competent adenovirus enhances cytotoxicity in bladder cancer. Journal of Urology, 168(1), 266-272.
  21. Arafat, WO., Gomez-Navarro, J., Buchsbaum, DJ., Xiang, J., Casado, E., Barker, SD., ... Curiel, DT. (2002). Effective single chain antibody (scFv) concentrations in vivo via adenoviral vector mediated expression of secretory scFv. Gene Therapy, 9(4), 256-262. https://doi.org/10.1038/sj.gt.3301639
  22. Witlox, M. A., van Beusechem, V. W., Grill, J., Haisma, H. J., Schaap, G., Bras, J., ... Wuisman, P. I. (2002). Epidermal growth factor receptor targeting enhances adenoviral vector based suicide gene therapy of osteosarcoma. J Gene Med, 4(5), 510 - 516. https://doi.org/10.1002/jgm.308
  23. 2001
  24. van Beusechem, VW., Grill, J., Mastenbroek, DCJ., Haisma, HJ., Wickham, TJ., Roelvink, PW., ... Gerritsen, WR. (2001). Highly specific adenovirus vectors for targeted cancer gene therapy. Cancer Gene Therapy, 8(9), 688-689.

ID: 207456